8-K: Vireo Growth Completes Schwazze Asset Acquisition, Expands Cannabis Footprint

Vireo Growth Inc. has finalized its acquisition of 45 dispensaries and two manufacturing facilities from Schwazze, expanding its cannabis operations in Colorado and New Mexico.

Summary

• Vireo Growth Inc. (Vireo) completed the acquisition of certain assets from Medicine Man Technologies, Inc. d/b/a Schwazze (Schwazze).
• The acquired assets include 45 dispensaries (24 in Colorado, 21 in New Mexico) and two manufacturing facilities (one in Colorado, one in New Mexico).
• The acquisition was executed through a credit bid of approximately $111 million in Schwazze's Senior Secured Notes and the assumption of certain specified liabilities.
• Vireo's wholly-owned subsidiary, CO Acquisition Vehicle, LLC, acquired the remaining Senior Secured Notes of Schwazze and became a lender in the new financing structure.
• CO Acquisition Vehicle, LLC has a $26,000,000 term loan facility at a fixed interest rate of 20.0% per annum, with interest payable in kind until June 3, 2026, and then monthly.
• Vireo Health of Rocky Mountain, LLC (NewCo), the acquiring entity, secured a senior secured term loan facility totaling approximately $62.7 million (Tranche A: ~$50 million, Tranche B: ~$12.7 million) at a fixed interest rate of 12.0% per annum, payable semi-annually.
• The transaction is expected to significantly expand Vireo's retail presence in Colorado and New Mexico, with potential growth to over 75 dispensaries.
• Justin Dye will become Chairman and Forrest Hoffmaster will be CEO of Vireo's Colorado and New Mexico-focused businesses.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a strategically positive development, as it expands Vireo's market presence at a favorable valuation, despite the high cost of debt reflecting industry-specific risks.

Positives

• Acquisition of 45 established dispensaries and two manufacturing facilities in Colorado and New Mexico.
• Expansion into key cannabis markets, aligning with a disciplined growth strategy.
• Acquisition at an implied estimated valuation of under 4x pro forma EBITDA, suggesting an attractive entry point.
• Strategic partnership with Justin Dye and Forrest Hoffmaster, bringing operational expertise and a strong retail focus.
• Potential for significant future growth, aiming for over 75 dispensaries in Colorado and New Mexico.
• Secured new financing facilities (CO Acquisition LSA and NewCo LSA) to support the acquisition and ongoing operations.

Negatives

• High interest rate of 20.0% per annum on the $26,000,000 CO Acquisition LSA.
• Make-whole amounts are payable if loans are prepaid or accelerated before specified dates (March 30, 2027 for CO Acquisition LSA, June 19, 2026 for NewCo LSA).
• Significant related-party involvement in financing, with Vireo's CEO being a partner in the administrative agent's affiliate.
• The business operates under US State Cannabis Laws that contravene US Federal Cannabis Laws, posing inherent legal risks.
• The filing explicitly mentions risks of adverse impact on business, financial condition, and results of operations due to the acquisition.

Risks

• Adverse impact of the acquisition on Vireo's business, financial condition, and results of operations.
• Challenges in maintaining relationships with suppliers, customers, employees, and other third parties post-acquisition.
• Uncertainties and effects of the acquisition on the Company and its various constituents.
• Potential for pending and future litigation, legal or regulatory proceedings, or governmental investigations and actions.
• Risks related to the timing and content of adult-use cannabis legislation in markets where the Company operates.
• Exposure to current and future market conditions, including fluctuations in the market price of the Company's subordinate voting shares.
• Risks related to epidemics and pandemics.
• Federal, state, local, and foreign government laws, rules, and regulations, especially U.S. federal and state cannabis laws and potential changes to them.
• Operational, regulatory, and other inherent risks in the cannabis industry.
• Challenges in managing growth effectively.
• Difficulties in accurately forecasting future events.
• Potential conflicts of interest due to related-party transactions.
• Risks inherent in an agricultural business (cannabis cultivation).
• Risks inherent in a manufacturing business (cannabis product manufacturing).
• Liquidity risks and the Company's ability to raise additional financing to continue as a going concern.
• Ability to meet the demand for flower in its various markets.
• Ability to dispose of assets held for sale at an acceptable price or at all.

Future Outlook

Vireo Growth Inc. plans to build a scaled retail presence in Colorado and New Mexico, potentially expanding to over 75 dispensaries over time, subject to market conditions, regulatory approvals, and capital availability. The company expects enhanced performance across the combined footprint with the acquired Schwazze assets.

Management Comments

• "We are pleased to announce the closing of the acquisition of the Schwazze assets. This transaction represents a meaningful step in the continued execution of our disciplined growth strategy, enabling Vireo to expand its presence in key markets through the acquisition of established retail operations at an implied estimated valuation of under 4x pro forma EBITDA. We believe this attractive entry point reflects current market conditions and underscores our focus on capital-efficient growth." John Mazarakis, CEO of Vireo.
• "We are honored to partner with Justin Dye, Forrest Hoffmaster, Collin Lodge, and the broader Colorado and New Mexico Schwazze team. Their operational expertise and strong retail focus complement Vireo's platform, and we look forward to working together to enhance performance across the combined footprint." John Mazarakis, CEO of Vireo.
• "This acquisition represents an initial step toward a broader strategy to build a scaled retail presence in Colorado and New Mexico, which could grow to over 75 dispensaries over time, subject to market conditions, regulatory approvals, and capital availability. We are pleased to welcome the Schwazze team and their established network of retail dispensaries to Vireo." John Mazarakis, CEO of Vireo.
• "This transaction marks the beginning of a new chapter for the Schwazze team. We are proud to contribute our capabilities to Vireo's growing platform and remain committed to serving our customers in Colorado and New Mexico with the high-quality products and experiences they expect." Forrest Hoffmaster, CEO of Vireo's Colorado and New Mexico-focused businesses.

Industry Context

StockSavvy.ai notes that this acquisition positions Vireo Growth Inc. as a more significant multi-state operator (MSO) in the U.S. cannabis market, particularly strengthening its footprint in Colorado and New Mexico. The stated acquisition valuation of "under 4x pro forma EBITDA" suggests a strategic move to capitalize on potentially undervalued assets in a consolidating industry, reflecting current market conditions where cannabis companies may be seeking capital-efficient growth opportunities amidst regulatory uncertainties. The emphasis on building a "scaled retail presence" aligns with a broader industry trend towards market dominance through extensive retail networks.

Comparison to Industry Standards

• The implied acquisition valuation of "under 4x pro forma EBITDA" is generally considered attractive in the cannabis industry, especially for established retail operations. For comparison, some larger, more mature MSOs have traded at higher EBITDA multiples in more favorable market conditions, while distressed assets might trade lower. This suggests Vireo secured the assets at a favorable price relative to historical industry benchmarks, possibly reflecting the current challenging capital environment for cannabis companies.
• The interest rate of 20.0% on the CO Acquisition term loan is significantly higher than traditional corporate financing, reflecting the elevated risk profile associated with the federally illegal status of cannabis in the U.S. and the specific financial distress of the acquired entity (Schwazze). This rate is comparable to high-yield debt or specialized cannabis lending rates, which often range from mid-teens to low twenties.
• The 12.0% interest rate on the NewCo LSA is also high but more favorable than the CO Acquisition LSA, indicating a potentially stronger credit profile for the newly formed entity or different risk assessment for that specific tranche.

Management Changes

Corporate Governance

Legal Proceedings

• The Company (Schwazze) is in default of its obligations under the Senior Notes Indenture, leading to the exercise of remedies by the Collateral Agent, including a public disposition of collateral under UCC Sections 9-610 and 9-611.
• The Asset Purchase Agreement and related transactions are intended to constitute a "Sale Proceeding" and a "public sale" under UCC, aiming to transfer assets free and clear of Liens.
• The filing includes a general risk factor about the nature, cost, impact, and outcome of pending and future litigation, other legal or regulatory proceedings, or governmental investigations and actions.

Related Party Transactions

• John Mazarakis, Vireo Growth Inc.'s Chief Executive Officer, is a partner of Chicago Atlantic Group, LP, an affiliate of Chicago Atlantic Admin, LLC (Collateral Agent for Schwazze Senior Notes and Administrative Agent for CO Acquisition LSA) and Chicago Atlantic Financial Services, LLC (Administrative Agent for NewCo LSA). This indicates significant related-party involvement in the financing and transaction.
• CO Acquisition Vehicle LLC, a wholly-owned subsidiary of Vireo Growth Inc., is a lender in the NewCo LSA, holding approximately $5.5 million of the Tranche A Term Loan and the entire $12.7 million Tranche B Term Loan.

Stakeholder Impact

• Shareholders (Vireo Growth Inc.): Potential for increased market presence and revenue growth through expanded operations, but also exposure to high-interest debt and integration risks.
• Shareholders (Schwazze): The transaction involves the discharge of Senior Secured Notes, indicating a restructuring due to default, likely resulting in significant losses for equity holders.
• Employees (Schwazze/Acquired Entities): Business Employees and Business Contingent Workers will receive offers of employment or engagement from Buyer or its affiliates, subject to terms determined by the Buyer.
• Customers (Acquired Dispensaries): The new management team (Forrest Hoffmaster as CEO) is committed to serving customers with high-quality products and experiences.
• Creditors (Schwazze Senior Noteholders): The credit bid of $111 million principal amount of Senior Secured Notes resulted in their discharge, indicating a resolution for these creditors.
• Creditors (NewCo/CO Acquisition Lenders): New secured term loans provide financing but come with specific covenants and high interest rates.

Next Steps

• Vireo Growth Inc. plans to build a scaled retail presence in Colorado and New Mexico, potentially growing to over 75 dispensaries.
• The Company Entities will continue to use commercially reasonable efforts to obtain necessary consents for contract assignments post-closing.
• The Company Entities will maintain books and records for three years post-closing or until liquidation proceedings are complete, providing access to the Buyer.
• The Company will prepare and deliver audited and unaudited financial statements by December 15, 2025.
• Obligors under the NewCo LSA must comply with financial covenants, including maintaining a Total Leverage Ratio of not more than 5.00 to 1.00 and minimum liquidity of $1,000,000, starting June 30, 2026.
• Obligors must deliver a completed Schedule 22 of the Information Certificate and evidence of intellectual property assignments by a specified date.
• Obligors must deliver Controlled Account Agreements for all non-excluded deposit/securities/commodity accounts by a specified date.

Key Dates

Recommendation

The acquisition of Schwazze's assets at an attractive valuation (under 4x pro forma EBITDA) and the strategic expansion in key cannabis markets are positive for Vireo Growth Inc.'s long-term growth prospects. However, the high interest rates on the new debt facilities (20% and 12%) and the inherent regulatory risks of operating in the U.S. cannabis market (federal illegality) introduce significant financial and operational challenges. The related-party nature of the financing also warrants close scrutiny. Given these mixed signals, a "hold" recommendation is appropriate, advising investors to monitor integration success, regulatory developments, and the company's ability to manage its debt burden and achieve its growth targets before making further investment decisions.

Keywords

Cannabis, Acquisition, Dispensaries, Manufacturing Facilities, Colorado, New Mexico, Vireo Growth Inc., Schwazze, SEC Filing, Asset Purchase Agreement, Senior Secured Notes, Term Loan, Financial Restructuring, Multi-State Operator, Cannabis Regulation, Corporate Finance